Osteoporosis
From the Journals
Low DHT linked to hip fracture in men
In older men, circulating levels of the androgen dihydrotestosterone and sex hormone binding globulin independently predict risk of hip fracture,...
Conference Coverage
Reassuring rheumatic disease patients on value of bisphosphonates
Dr. Marcy B. Bolster addresses common patient concerns about bisphosphonate use.
Conference Coverage
Longer bisphosphonate use ups AFF risk, but not all is tied to drug
The clinical implications of research to date are that “the risk of AFF should not dissuade patients and providers from short-term use of...
Conference Coverage
Treat-to-target strategy ‘not ready for primetime’ in osteoporosis
Debaters at a session of the recent virtual ASBMR 2020 annual meeting could have gone either way on this topic, but data and evidence are...
From the Journals
Trabecular bone loss may contribute to axial spondyloarthritis progression
Severe trabecular bone loss is associated with syndesmophyte formation in axial spondyloarthritis.
Conference Coverage
More dairy lowers risk of falls, fractures in frail elderly
Results from the first randomized trial to show a benefit of dairy food intake on risk of fractures leave it unclear whether it is better to get...
Conference Coverage
Mega vitamin D harms bone in women, not men, without osteoporosis
Conference Coverage
ASBMR 2020: Sequential osteoporosis meds, AI, bone cancer, and more
The virtual meeting will provide the latest information about basic research and clinical treatment of bone disease, from sequential osteoporosis...
From the Journals
CagA-positive H. pylori patients at higher risk of osteoporosis, fracture
Study adds additional weight to previous findings regarding H. Pylori infection and bone fragility, particularly among CagA-positive...
From the Journals
Atypical fractures with bisphosphonates highest in Asians, study confirms
The benefits of bisphosphonates in fracture reduction still far outweigh risks for atypical femur fractures, but the study shows a higher risk for...
From the Journals
SGLT2 inhibitors with metformin look safe for bone
A meta-analysis of clinical trials finds no significant increase in fracture rate in type 2 diabetes patients taking SLGT-2 inhibitors plus...